Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-β

Neurobiology of Disease

Volumn 58, Issue , 2013, Pages 249-257

  Yoo, Seung Wan ^a   Chang, Da Young ^a   Lee, Hye Sun ^a   Kim, Gyu Hee ^a,b   Park, Jin Sung ^a,b   Ryu, Buom Yong ^c   Joe, Eun Hye ^a,b   Lee, Young Don ^a,b   Kim, Sung Soo ^a   Suh Kim, Haeyoung ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

Cell death; Inflammation; Mesenchymal stem cell; Microglia; Stroke; TGF

Indexed keywords

CD68 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

CELL DEATH; INFLAMMATION; MESENCHYMAL STEM CELL; MICROGLIA; STROKE; TGF-Β;

ANIMALS; ANTIGENS, CD; BLOOD-BRAIN BARRIER; BRAIN INFARCTION; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROFILAMENT PROTEINS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84880175343     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.06.001     Document Type: Article

References (51)

1. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., Petrek M. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm. 2005, 2005:175-179.
2. Banisadr G., Gosselin R.D., Mechighel P., Kitabgi P., Rostene W., Parsadaniantz S.M. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J. Comp. Neurol. 2005, 489:275-292.
3. Becker K.J. Modulation of the postischemic immune response to improve stroke outcome. Stroke 2010, 41:S75-S78.
4. Benveniste E.N., Nguyen V.T., O'Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 2001, 39:381-391.
5. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 2006, 98:1076-1084.
6. Castellanos M., Serena J. Applicability of biomarkers in ischemic stroke. Cerebrovasc. Dis. 2007, 24(Suppl. 1):7-15.
7. Chang S.A., Lee E.J., Kang H.J., Zhang S.Y., Kim J.H., Li L., et al. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cells 2008, 26:1901-1912.
8. Chopp M., Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 2002, 1:92-100.
9. Dimitrijevic O.B., Stamatovic S.M., Keep R.F., Andjelkovic A.V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007, 38:1345-1353.
10. Duijvestein M., Vos A.C., Roelofs H., Wildenberg M.E., Wendrich B.B., Verspaget H.W., et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010, 59:1662-1669.
11. Feinberg M.W., Shimizu K., Lebedeva M., Haspel R., Takayama K., Chen Z., et al. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ. Res. 2004, 94:601-608.
12. Hemmer B., Archelos J.J., Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 2002, 3:291-301.
13. Honmou O., Houkin K., Matsunaga T., Niitsu Y., Ishiai S., Onodera R., et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011, 134:1790-1807.
14. Hughes P.M., Allegrini P.R., Rudin M., Perry V.H., Mir A.K., Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 2002, 22:308-317.
15. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18117-18122.
16. Ji K.A., Yang M.S., Jeong H.K., Min K.J., Kang S.H., Jou I., et al. Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain. Glia 2007, 55:1577-1588.
17. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
18. Kim S.S., Choi J.M., Kim J.W., Ham D.S., Ghil S.H., Kim M.K., et al. cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. NeuroReport 2005, 16:1357-1361.
19. Kim S.S., Yoo S.W., Park T.S., Ahn S.C., Jeong H.S., Kim J.W., et al. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008, 26:2217-2228.
20. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
21. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:770-774.
22. Labouyrie E., Dubus P., Groppi A., Mahon F.X., Ferrer J., Parrens M., et al. Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol. 1999, 154:405-415.
23. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97.
24. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
25. Lee S.T., Chu K., Jung K.H., Kim S.J., Kim D.H., Kang K.M., et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008, 131:616-629.
26. Li M.O., Flavell R.A. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008, 28:468-476.
27. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006, 24:99-146.
28. Li W.Y., Choi Y.J., Lee P.H., Huh K., Kang Y.M., Kim H.S., et al. Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant. 2008, 17:1045-1059.
29. Mahmood A., Lu D., Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma. 2004, 21:33-39.
30. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Shudou M., Ii C., et al. Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J. Neurosci. Res. 2007, 85:994-1009.
31. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
32. Oh J.Y., Kim M.K., Shin M.S., Lee H.J., Ko J.H., Wee W.R., et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 2008, 26:1047-1055.
33. Pan W., Kastin A.J. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog. Neurobiol. 2007, 83:363-374.
34. Pang L., Ye W., Che X.M., Roessler B.J., Betz A.L., Yang G.Y. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 2001, 32:544-552.
35. Parr A.M., Tator C.H., Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007, 40:609-619.
36. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
37. Ringden O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lonnies H., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006, 81:1390-1397.
38. Shyy J.Y., Li Y.S., Lin M.C., Chen W., Yuan S., Usami S., et al. Multiple cis-elements mediate shear stress-induced gene expression. J. Biomech. 1995, 28:1451-1457.
39. Stumm M.M., D'Orazio D., Sumanovski L.T., Martin P.Y., Reichen J., Sieber C.C. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver 2002, 22:441-450.
40. Sung Park J., Chang D.Y., Kim J.H., Hwa Jung J., Park J., Kim S.H., et al. Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells. Exp. Mol. Med. 2013, 45:e10.
41. Thored P., Arvidsson A., Cacci E., Ahlenius H., Kallur T., Darsalia V., et al. Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 2006, 24:739-747.
42. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 2006, 36:2566-2573.
43. Uccelli A., Zappia E., Benvenuto F., Frassoni F., Mancardi G. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert. Opin. Biol. Ther. 2006, 6:17-22.
44. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 2005, 33:1402-1416.
45. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:5788-5792.
46. Wang X., Yue T.L., Barone F.C., Feuerstein G.Z. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 1995, 26:661-665. (discussion 665-6).
47. Wolf G., Jocks T., Zahner G., Panzer U., Stahl R.A. Existence of a regulatory loop between MCP-1 and TGF-beta in glomerular immune injury. Am. J. Physiol. Renal Physiol. 2002, 283:F1075-F1084.
48. Yamagami S., Tamura M., Hayashi M., Endo N., Tanabe H., Katsuura Y., et al. Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J. Leukoc. Biol. 1999, 65:744-749.
49. Yoo S.W., Kim S.S., Lee S.Y., Lee H.S., Kim H.S., Lee Y.D., et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 2008, 40:387-397.
50. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15769-15774.
51. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755-1761.